PAEDIATRIC THYROID CANCER DAY
The day is open to clinicians of all levels and craft groups, and basic/clinical researchers interested in Paediatric Thyroid Cancer.
DATE: Monday 22 May 2023
TIME: Full day
VENUE: Rydges, Sydney Central (and online)
The hotel is located a convenient 5 min walk from Central Station - allowing easy connection from the airport and other Sydney suburbs.
ANZSPED would like to recognise the generous support of the following company, making this day possible:
PROGRAM
| 0800 | Registration | |
| 0845 | Welcome | |
| 0900 | Current Management for paediatric thyroid cancer: A global perspective | Prof Andrew Bauer Perelman School of Medicine, University of Pennsylvania & Children's Hospital of Philadelphia's (CHOP) Thyroid Center |
| 0940 | Evolving models of Care, MDTs and The APTCaR collaboration | A/Prof. Paul Benitez-Aguirre Sydney Children's Hospital Network |
| 1015 | Morning tea | |
| 1045 | An update on the pathology and diagnostics of Paediatric Thyroid cancer, diagnostic challenges and what lies ahead. | Prof Anthony Gill University of Sydney |
| 1120 | Challenges in Paediatric Thyroid Cancer Surgery - Surgical approaches | Dr Gideon Sandler The Children's Hospital at Westmead |
| 1155 | Nuclear medicine diagnostics and therapy in paediatric thyroid cancer | Dr David Chung Sydney Children's Hospital Network |
| 1230 | Lunch | |
| 1330 | Panel discussion : Familial Thyroid Cancers – a clinical perspective from childhood to adult care | Prof Bruce Robinson (Lead presenter) Prof Kathy Tucker (Genetics) Prof Andrew Bauer (Paediatric endocrinology) Dr Gideon Sandler (Surgery) Dr Ted Laetsch (Oncology) |
| 1430 | Paediatric thyroid cancer: The Australian Oncology Experience – ANZCHOG and The Zero Collaboration. Challenging cases. | Dr Antoinette Anazodo Sydney Children's Hospital Network |
| 1500 | Afternoon Tea | |
| 1530 1550 | Not all that wheezes is Asthma Is it time for a new approach to Thyroid Cancer Management | Dr Farrah Rodrigues The Children's Hospital, Melbourne Dr Rebecca Cramer The Children's Hospital at Westmead |
| 1615 | Novel Targeted Therapies in Paediatric Thyroid Cancer | Dr Theodore (Ted) Laetsch Children’s Hospital of Philadelphia |
| 1715 | Thyroid Cancer in Adult care - The Transitioned patient and contrasts with therapies in adult settings | Dr Matti Gild The University of Sydney |
| 1745 | Q & A | |
| 1800 | Close of day followed by 'Canapes and Conversation' | |
| 1930 | Optional Dinner - booked at time of registration | |
REGISTRATION
Each person attending the conference needs to complete their own registration (see link at bottom of screen) and provide payment details to the Conference Secretariat. This includes invited speakers, chairpersons and all other delegates.
Please read the details below before completing the online registration.
INCLUSIONS IN REGISTRATION
- Attendance at all sessions (either in person or online, depending on registration type)
- Catering as scheduled during the day (if attending in person)
- Access to recordings of sessions post conference
FEES
| All Fees inc GST | REGISTRATION FEE On or before 27 March 2023 | REGISTRATION FEE On or after 28 March 2023 |
| Nurse/Allied Health/Trainee | $50 | $90 |
| Medical | $100 | $150 |
| Online | $30 | $30 |
A summary of your registration and a tax invoice will be emailed to you within seven working days.
CANCELLATIONS AND REFUNDS
Cancellations must be notified in writing to the Conference Secretariat.
- Cancellations received
- On or before 27 March 2023 you will receive a refund of monies paid, less $50 administration fee
- On or after 28 March 2023, there will be no refund
ACKNOWLEDGEMENTS
Your registration will be acknowledged by return email with confirmation of your requirements according to your registration form. Bookings will be confirmed only on receipt of payment.
TO REGISTER
Please click below to register for the meeting.
Faculty - International
Andrew Bauer
Prof Andy Bauer MD, is a Professor of Paediatrics at the Perelman School of Medicine, University of Pennsylvania and serves as the director of the Children's Hospital of Philadelphia's Thyroid Center. Dr. Bauer’s clinical and research interests span across the spectrum of paediatric thyroid disorders, including hyperthyroidism, hypothyroidism, thyroid hormone resistance and transport disorders, thyroid nodular disease, thyroid cancer, and familial thyroid tumour syndromes. Within this field, he has published more than 120 manuscripts, chapters and reviews and is a regularly invited lecturer and visiting professor at international meetings and academic institutes.
Ted Laetsch
Dr. Theodore Laetsch is a paediatric oncologist and leads both the Developmental Therapeutics Program (DVL) and the Very Rare Malignant Tumours Program (VRMTP) at the Children’s Hospital of Philadelphia, as well as holding national leadership roles in each of these areas within the Children’s Oncology Group (COG).
In the DVL program, Dr. Laetsch conducts early phase clinical trials of new treatments for children with difficult to treat cancers, with a particular area of focus including molecularly targeted therapies that are designed to block specific genetic mutations identified in patients' tumors. In particular, Dr. Laetsch leads the pediatric development of TRK inhibitors for children with NTRK gene fusions, and now leads a COG nationwide clinical trial studying the ability to use TRK inhibitors instead of chemotherapy for children with one of these gene fusions.
Faculty - National
Dr Antoinette Anazodo
Antoinette Anazodo trained in paediatric and adolescent oncologist. Dr Anazodo was appointed as Director, Adolescent and Young Adult Cancer at Sydney Children’s Hospital, Randwick and Prince of Wales Hospital in October 2010. She is developing the AYA cancer service to ensure all AYA patients have access to appropriate age and tumour specific medical treatment as well as ensuring they benefit from psychosocial assessment and care navigation through treatment.
Assoc. Prof. Paul Benitez-Aguirre
Paul Benitez-Aguirre is a Paediatric Endocrinologist at the SCHN. He is Chair of the ANZPED Paediatric Thyroid Working Group and Founder and Co-Chair of the SCHN Paediatric Thyroid Cancer MDT Service. He leads the development of the Australasian Paediatric Thyroid Cancer Register (APTCaR).
Dr David Chung
Dr David Chung is a Senior Staff Specialist at the SCHN. He is an expert in diagnostic and therapeutic aspects of Nuclear Medicine in public and private services and is a Lecturer at the University of Sydney. He has extensive expertise in Neck and thyroid Sonology.
Dr Matti Gild
Dr Matti Gild is a Staff Specialist in Endocrinology at Royal North Shore Hospital, Sydney and a Senior Lecturer in Medicine at the University of Sydney. Matti chairs the Thyroid Cancer Research Group at the University of Sydney which facilitates translational research projects. Her clinical research is focussed on de-escalation of treatment and optimising patient outcomes in thyroid cancer. She maintains her basic science platform investigating genetic drivers of thyroid cancer at the Kolling Institute of Medical Research.
Prof Anthony Gill
Professor Anthony J Gill AM (MBBS MD FRCPA) is Professor of Surgical Pathology at the University of Sydney, a senior staff specialist in anatomical pathology at the Royal North Shore Hospital in Sydney and chairman of the Australian Pancreatic Genome Initiative (APGI). His scope of clinical practice includes both anatomical (surgical and cytological) pathology and targeted molecular testing of tumours, with an emphasis on biomarker development and companion diagnostic testing for targeted therapies.
Prof Bruce Robinson
Professor Bruce Robinson is an endocrinologist with extensive and wide-ranging experience as an academic, physician, and scientist. He has a particular interest in endocrine cancers and has other interests ranging across research, healthcare, medicine and tertiary education.
Professor Robinson is chair of the Australian Government’s taskforce of expert clinicians charged with reviewing the Medicare Benefits Schedule and also chairs Australia’s peak advisory and funding body for medical research, National Health and Medical Research Council. He is the former head of the Cancer Genetics Unit at the Kolling Institute of Medical Research and head of medicine at Royal North Shore Hospital where he practices today. Bruce is the former dean at the University of Sydney’s Medical School.
Dr Gideon Sandler
Dr Gideon Sandler is a Surgical Oncologist at Westmead Hospital, and the Children’s Hospital at Westmead, and a Clinical Lecturer at the University of Sydney. He is one of a handful of general surgeons fully engaged in surgical oncology in adults and children. His interests include thyroid and parathyroid surgery, salivary gland malignancy, surgical management of paediatric solid organ malignancy, and adult sarcoma and advanced cutaneous malignancies.
A/Prof Kathy Tucker AO
Associate Professor Kathy Tucker is a clinical cancer geneticist with extensive experience in cancer genetics. She founded the first Australian Familial Cancer Service in 1994 and is the former head of the Hereditary Cancer Centre, Prince of Wales Hospital as well as a conjoint of the POWH Clinical school of the University of New South Wales. Since founding this service, Associate Professor Tucker has been actively involved in local, state-wide and national working parties on genetics service and policy development.
Kathy is a Chief Investigator for the PREDICT Cancer Predisposition study. Leveraged through the Zero Childhood Cancer Program network, this study will allow us to identify gene variants of possible clinical significance and to identify families susceptible to the development of cancer and rare diseases.